Dosidal · Poland
Incresync
Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.
| Market | Poland |
|---|---|
| Record | pl:presentation:89388 (version 1) |
| Level | presentation |
| Pack code | not anchored |
| Identifiers | rpl-pack-id: 89388 eu-number: EU/1/13/842/006 |
| Source authority | URPL |
| Read date | 2026-11-15T02:02:49Z |
| controlled status | availability_category: Rp definitions: https://eli.gov.pl/eli/DU/2016/1769/ogl/pol/pdf narcotic_or_psychotropic: False state: current · read 2026-11-15T02:02:49Z · source: URPL / Rejestr Produktów Leczniczych (Centrum e-Zdrowia export) page |
| identity | atc: A10BD09 deleted: False eu_pack_number: EU/1/13/842/006 form: Tabletki powlekane holder: Takeda Pharma A/S medicine: Incresync pack_units: jednostkaPojemnosci: tabl. pojemnosc: 60 procedure: CEN routes: doustna strength: 12,5 mg + 30 mg substances: amount: 12,5 substance: Alogliptinum unit: mg; amount: 30 substance: Pioglitazonum unit: mg state: current · read 2026-11-15T02:02:49Z · source: URPL / Rejestr Produktów Leczniczych (Centrum e-Zdrowia export) page |
| pack product code | state: unknown |
| prescription class | availability_category: Rp definitions: https://eli.gov.pl/eli/DU/2016/1769/ogl/pol/pdf prescription: True state: current · read 2026-11-15T02:02:49Z · source: URPL / Rejestr Produktów Leczniczych (Centrum e-Zdrowia export) page |
| Signature | ES256 over JCS, key dosidal-record-1.9dbf5d53ZJh2b6jOwl7sEUqsfQ3fl_bg8dXkgvw9imzU1KsUdOP4XXwnogx1T_MjzcLcXQvCL_sFic6czMcbg32QapMmYQVerify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json |
JSON: https://dosidal-api.ai/v1/records/pl:presentation:89388 · Related records in other markets · Dosidal